Fact based stock research
COSMOS Pharmaceutical (TSE:3349)

JP3298400007

COSMOS Pharmaceutical stock research in summary

cosmospc.co.jp


COSMOS Pharmaceutical shares are less expensive than other comparable stocks. They show above average growth, are good value and are safely financed. We recommend evaluating whether the future of the company COSMOS Pharmaceutical is really as difficult as the low price of the stock suggests. If you believe that the future of the company is market-typical or even better, then this could be an argument for a share purchase.


Latest Obermatt Ranks


Country Japan
Industry Drug Retail
Index
Size class X-Large

May 7, 2021. Stock data may be delayed. Login to get the most recent research.


Research History: COSMOS Pharmaceutical

RESEARCH HISTORY 2018 2019 2020 2021
VALUE
VALUE
GROWTH
GROWTH
SAFETY
SAFETY
COMBINED
COMBINED

Last update of Combined Rank: 7-May-2021. Financial reporting date used for calculating ranks: 30-Nov-2020. Stock research history is based on the Obermatt Method. The higher the rank, the better COSMOS Pharmaceutical is in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2018 2019 2020 2021
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S)
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E)
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book)
DIVIDEND YIELD
DIVIDEND YIELD
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE

Last update of Value Rank: 7-May-2021. Stock analysis on value ratios: The higher the rank, the lower the value ratio of COSMOS Pharmaceutical; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2018 2019 2020 2021
REVENUE GROWTH
REVENUE GROWTH
PROFIT GROWTH
PROFIT GROWTH
STOCK RETURNS
STOCK RETURNS
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH

Last update of Growth Rank: 30-Nov-2020. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of COSMOS Pharmaceutical.


Safety Metrics in Detail

SAFETY METRICS 2018 2019 2020 2021
LEVERAGE
LEVERAGE
REFINANCING
REFINANCING
LIQUIDITY
LIQUIDITY
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY

Last update of Safety Rank: 30-Apr-2021. Stock analysis on safety metrics: The higher the rank, the lower the leverage of COSMOS Pharmaceutical and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for COSMOS Pharmaceutical from May 7, 2021.


We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.

Get stock news now

Investing made easy